Ankle pain?
Our latest implant, Episealer Talus, an individualised technology for the treatment of cartilage lesions in the ankle.
Information for healthcare professionals Information for patients
Truly individualised
Every step in the Episealer process
revolves around you, the patient.
”My knee does not limit me anymore; I can do everything I want to do”
Read how an Episealer helped Göran back to an active life
Link to testimonial
Episealer® Knee Publication: Implant Survivorship Analysis up to Seven Years Post-Implantation
The analysis shows successful results
Link to publication
Orthopaedic Implants & Surgical Instruments
Presentation from Episurf Medical Capital Markets Day on September 15, 2020
During the Capital Markets Day, members of the management team and key customers and co-operation partners of Episurf presented various aspects of the business. All presentations are available in the link.
Episealer, the only individualised implant
for focal cartilage lesions in the knee
Each Episealer implant is unique,
carefully designed to match your anatomy perfectly.
Arthritis,
a painful joint disease resulting from the breakdown of cartilage and underlying bone
Each year, more and more people are diagnosed with arthritis.
Episurf wants to help you who suffers from knee pain with early signs of arthritis to return to the life you want to live.
The Episealer process
To ensure you receive the best possible treatment for your cartilage lesion, every step in the process focuses on you. First, an MRI scan of your knee is needed. This scan will then be used to compose a damage marking report, including a virtual 3D model of your knee joint. This 3D model will be the basis for the design of your individualised Episealer implant and surgical instrument kit. Below you can read more about each step.
Damage Marking Report
These images are then used to create a
virtual 3D model and visualisation
of your knee joint
Episealer
This 3D model is the basis for the
design of your individualised
Episealer implant
“My quality of life today has really improved”
Interim Report Q3 2020
Click here to readWatch our CEO Pål Ryfors latest presentations
Watch them here
